Skip to main content
Premium Trial:

Request an Annual Quote

Ciphergen s Investigation Into Revenue Issues Holds Up Q3 Financials

NEW YORK, Nov. 7 (GenomeWeb News) - Ciphergen said today that its audit committee is investigating the recognition of around $500,000 in sales recorded in the second quarter.

 

As a result, the company, which has enlisted the help of undisclosed "external accounting advisors," said it is delaying the release of its third-quarter financial results.

 

Last Wednesday, a notice on Ciphergen's web site said the company planned to issue its third-quarter earnings the following day. However, that notice had been removed when a GenomeWeb News reporter revisited the site on Thursday. A Ciphergen spokeswoman said last week the notice had been posted on the web site in error.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more